ITHACA, N.Y. — Richard A. Montagna, Ph.D., senior vice president for scientific and clinical affairs at Rheonix Inc., a developer of fully automated molecular diagnostics solutions, has been accepted as a Fellow of the National Academy of Clinical Biochemistry (NACB).
Fellowship in NACB is open to members of the American Association of Clinical Chemistry (AACC) who are doctoral-level clinical scientists. Fellows must hold American Board of Clinical Chemistry or equivalent board… Read More »
ITHACA, N.Y. – March 24, 2014 - Rheonix, Inc., a developer of fully automated molecular testing solutions, announced today that it has been invited to exhibit at “The Future of In-Vitro Diagnostics.” The exclusive conference, held April 10, 2014 in Menlo Park/Palo Alto, CA, is hosted by Siemens Venture Capital, the investment arm of Siemens, and Siemens Healthcare.
The fifth annual conference brings together over 100 CEOs and CTOs, investors, key… Read More »
ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular diagnostics solutions, has been granted six additional patents for its core microfluidic device, the Chemistry and Reagent Device, or CARD® . One patent was issued Feb. 11, while the other five have been allowed but not yet issued.
The Rheonix CARD is a disposable cartridge the size of a credit card that runs multiple samples simultaneously without user intervention. Once… Read More »
ITHACA, N.Y. — Rheonix, Inc., a developer of fully automated molecular testing solutions, has created a channel-free microfluidic device, the Rheonix Smart FilmCARD™. The Smart FilmCARD would be the first microfluidic device in the diagnostics industry with no channels included in its design, a breakthrough that will significantly decrease the research, development and production costs of microfluidic solutions and allow sophisticated diagnostic tests to become more widely available. The Smart… Read More »
ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, has established the Rheonix Innovation Center to allow the company to continue to develop core technology within its expansive intellectual property portfolio. The center is adjacent to the company’s new headquarters in Ithaca, N.Y.
Employees within the center will be tasked with applying Rheonix’s technical capabilities to solving molecular testing challenges outside the traditional scope of automated molecular… Read More »